Actively Recruiting
Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors
Led by Pietro Mortini, MD, Prof. · Updated on 2025-06-11
200
Participants Needed
1
Research Sites
365 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to characterize the circulating leukocyte profile and the immune T cells distribution within the tumor in patients with malignant brain tumors and to correlate these findings with the oncological outcome. Participants will be subjected to blood sampling before surgery and for 12 months of follow-up. Additional sampling and analysis will be performed on tumor samples.
CONDITIONS
Official Title
Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients (≥18 years)
- Able to express informed consent
- With primary or secondary malignant brain tumor
- Requiring neurosurgical treatment (radiosurgery, stereotactic biopsy, surgery)
You will not qualify if you...
- Patients who do not meet inclusion criteria.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS San Raffaele Scientific Institute
Milan, Milan, Italy, 20132
Actively Recruiting
Research Team
L
Laura Sincinelli
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here